1. The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan.
   In: Social Science & Medicine.
   RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055.

   Full description at Econpapers || Download paper

1. Appleby J, Devlin N, Parkin D, Buxton M, Chalkidou K., Searching for cost effectiveness thresholds in the NHS. Health Policy. 2009;91(3):239–45.

2. Birch S, Gafni A., Changing the problem to fit the solution: Johannesson and Weinstein’s (mis) application of economics to real world problems. J Health Econ. 1993;12(4):469–76.
   Paper not yet in RePEc: Add citation now
   
3. Claxton K, Martin S, Soares M, , et al, . Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess. 2015;19(14):1–503.
   Paper not yet in RePEc: Add citation now
   
4. Culyer AJ., Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use. Health Econ Policy Law. 2016;11(4):415–32.
   Paper not yet in RePEc: Add citation now
   
5. Edney LC, Afzali HHA, Cheng TC, Karnon J., Estimating the reference incremental cost-effectiveness ratio for the Australian health system. Pharmacoeconomics. 2018;36(2):239–52.
   Paper not yet in RePEc: Add citation now
   
6. Johannesson M, Weinstein MC., On the decision rules of cost-effectiveness analysis. J Health Econ. 1993;12(4):459–67.
   Paper not yet in RePEc: Add citation now
   

7. Karlsberg Schaffer S, Sussex J, Devlin N, Walker A, . Local health care expenditure plans and their opportunity costs. Health Policy. 2015;119(9):1237–44.

8. Karlsberg Schaffer S, Sussex J, Hughes D, Devlin N, . Opportunity costs and local health service spending decisions: a qualitative study from Wales. BMC Health Serv Res. 2016;16(1):103.
   Paper not yet in RePEc: Add citation now
   
9. Karlsson G, Johannesson M., The decision rules of cost-effectiveness analysis. Pharmacoeconomics. 1996;9(2):113–20.
   Paper not yet in RePEc: Add citation now
   
10. Paulden M, O’Mahony J, McCabe C., Determinants of change in the cost-effectiveness threshold. Med Decis Making. 2017;37(2):264–76.
    Paper not yet in RePEc: Add citation now
    
11. Siverskog J, Henriksson M., Estimating the marginal cost of a life year in Sweden’s public healthcare sector. Eur J Health Econ. 2019;20(5):751–62.
    Paper not yet in RePEc: Add citation now
    
12. Thokala P, Ochalek J, Leech AA, Tong T., Cost-effectiveness thresholds: the past, the present and the future. Pharmacoeconomics. 2018;36(5):509–22.
    Paper not yet in RePEc: Add citation now
    
13. Weinstein M, Zeckhauser R., Critical ratios and efficient allocation. J Public Econ. 1973;2(2):147–57.
    Paper not yet in RePEc: Add citation now
    

1. Competition, value-based prices and incentives to research personalised drugs. (2024). LEVAGGI, ROSELLA.
   In: Socio-Economic Planning Sciences.
   RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697.

   Full description at Econpapers || Download paper

2. The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS. (2022). Asaria, Miqdad ; Baal, Pieter ; Perry-Duxbury, Megan ; Lomas, James.
   In: PharmacoEconomics.
   RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-021-01090-x.

   Full description at Econpapers || Download paper

3. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy. (2022). Towse, Adrian ; Sampson, Christopher ; Devlin, Nancy ; Garcia-Lorenzo, Borja ; Zamora, Bernarda ; Leech, Ashley A ; Watson, Sam ; Cubi-Molla, Patricia ; Chalkidou, Kalipso ; Cairns, John ; Hughes, Dyfrig A.
   In: Applied Health Economics and Health Policy.
   RePEc:spr:aphecp:v:20:y:2022:i:5:d:10.1007_s40258-022-00730-3.

   Full description at Econpapers || Download paper

4. Strategies for Avoiding Neglect of Opportunity Costs by Decision-Makers. (2022). Karnon, Jonathan ; Afzali, Hossein ; Partington, Andrew.
   In: Applied Health Economics and Health Policy.
   RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00681-1.

   Full description at Econpapers || Download paper

5. Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment. (2022). Faria, Rita ; Ochalek, Jessica ; Lomas, James.
   In: Applied Health Economics and Health Policy.
   RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00679-9.

   Full description at Econpapers || Download paper

6. The relevance of including future healthcare costs in cost-effectiveness threshold calculations for the UK NHS. (2022). Asaria, Miqdad ; van Baal, Pieter ; Perry-Duxbury, Megan ; Lomas, James.
   In: LSE Research Online Documents on Economics.
   RePEc:ehl:lserod:112503.

   Full description at Econpapers || Download paper

7. The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan.
   In: Social Science & Medicine.
   RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055.

   Full description at Econpapers || Download paper

8. NICE’s Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests. (2021). Paulden, Mike ; Omahony, James F ; McCabe, Chris.
   In: PharmacoEconomics.
   RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00990-8.

   Full description at Econpapers || Download paper

9. Mutually Exclusive Interventions in the Cost-Effectiveness Bookshelf. (2020). Henriksson, Martin ; Siverskog, Jonathan.
   In: Medical Decision Making.
   RePEc:sae:medema:v:40:y:2020:i:3:p:399-403.

   Full description at Econpapers || Download paper

10. Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL). (2018). Hampson, Grace ; Garau, Martina ; Devlin, Nancy ; Profico, Antonio ; Mazzanti, Nicola Amedeo.
    In: PharmacoEconomics - Open.
    RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0048-x.

    Full description at Econpapers || Download paper

11. Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Edney, Laura Catherine ; Karnon, Jonathan ; Ali, Hossein Haji.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

    Full description at Econpapers || Download paper

12. Using CART to Identify Thresholds and Hierarchies in the Determinants of Funding Decisions. (2017). Mortimer, Duncan ; Dalziel, Kim ; Schilling, Chris.
    In: Medical Decision Making.
    RePEc:sae:medema:v:37:y:2017:i:2:p:173-182.

    Full description at Econpapers || Download paper

13. Rationing in health care provision: a welfare approach. (2017). LEVAGGI, ROSELLA.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:17:y:2017:i:2:d:10.1007_s10754-016-9209-1.

    Full description at Econpapers || Download paper

14. Sustainable Financing of Innovative Therapies: A Review of Approaches. (2016). Hollis, Aidan.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0416-x.

    Full description at Econpapers || Download paper

15. Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma. (2016). Polinder, Suzanne ; Bruno, Marco J ; Peppelenbosch, Maikel P ; Lordick, Florian ; Janmaat, Vincent T ; Lorenzen, Sylvie.
    In: PLOS ONE.
    RePEc:plo:pone00:0153943.

    Full description at Econpapers || Download paper

16. Welfare analysis of rationing in health care provision. (2016). LEVAGGI, ROSELLA.
    In: Working papers.
    RePEc:ipu:wpaper:39.

    Full description at Econpapers || Download paper

17. Supporting the development of an essential health package: principles and initial assessment for Malawi. (2016). Sculpher, Mark ; Revill, Paul ; Claxton, Karl ; Ochalek, Jessica ; Rollinger, Alexandra.
    In: Working Papers.
    RePEc:chy:respap:136cherp.

    Full description at Econpapers || Download paper

18. The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions. (2015). Rice, Nigel ; Parkin, David ; O'Neill, Phill ; Feng, Yan ; Devlin, Nancy ; Dakin, Helen.
    In: Health Economics.
    RePEc:wly:hlthec:v:24:y:2015:i:10:p:1256-1271.

    Full description at Econpapers || Download paper

19. Local health care expenditure plans and their opportunity costs. (2015). Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Devlin, Nancy ; Sussex, Jon ; Walker, Andrew.
    In: Health Policy.
    RePEc:eee:hepoli:v:119:y:2015:i:9:p:1237-1244.

    Full description at Econpapers || Download paper

20. STAR€”People-Powered Prioritization. (2014). Airoldi, Mara ; Bevan, Gwyn ; Morton, Alec.
    In: Medical Decision Making.
    RePEc:sae:medema:v:34:y:2014:i:8:p:965-975.

    Full description at Econpapers || Download paper

21. Pricing schemes for new drugs: A welfare analysis. (2014). LEVAGGI, ROSELLA.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:102:y:2014:i:c:p:69-73.

    Full description at Econpapers || Download paper

22. Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall. (2013). van Exel, Job ; Brouwer, Werner ; Wetering, E. ; Stolk, E..
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:14:y:2013:i:1:p:107-115.

    Full description at Econpapers || Download paper

23. Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold. (2013). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Barnsley, P ; Sussex, J.
    In: Occasional Paper.
    RePEc:ohe:occpap:000106.

    Full description at Econpapers || Download paper

24. The influence of cost-effectiveness and other factors on NICE decisions. (2013). Rice, Nigel ; Parkin, David ; Devlin, Nancy ; Feng, Yan ; OaNeill, Phill ; Dakin, Helen.
    In: Working Papers.
    RePEc:chy:respap:93cherp.

    Full description at Econpapers || Download paper

25. Comparing costs and outcomes across programmes of health care. (2012). Rice, Nigel ; Martin, Stephen ; Smith, Peter C..
    In: Health Economics.
    RePEc:wly:hlthec:v:21:y:2012:i:3:p:316-337.

    Full description at Econpapers || Download paper

26. The Cost Effectiveness of Newer Epilepsy Treatments. (2012). Bolin, Kristian ; Forsgren, Lars .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:30:y:2012:i:10:p:903-923.

    Full description at Econpapers || Download paper

27. The monetary value of a life year: evidence from a qualitative study of treatment costs. (2011). Richardson, Jeff ; Hurworth, Rosalind ; McKie, John ; Shrimpton, Bradley .
    In: Health Economics.
    RePEc:wly:hlthec:v:20:y:2011:i:8:p:945-957.

    Full description at Econpapers || Download paper

28. Welfare properties of restrictions to health care based on cost effectiveness. (2011). LEVAGGI, ROSELLA.
    In: Health Economics.
    RePEc:wly:hlthec:v:20:y:2011:i:1:p:101-110.

    Full description at Econpapers || Download paper

29. Shifting the risk in pricing and reimbursement schemes? A model of risk-sharing agreements for innovative drugs. (2011). LEVAGGI, ROSELLA ; Capri, Stefano.
    In: DEP - series of economic working papers.
    RePEc:gea:wpaper:2/2011.

    Full description at Econpapers || Download paper

30. Appropriate Perspectives for Health Care Decisions. (2010). Walker, Simon ; Sculpher, Mark ; Claxton, Karl ; Palmer, Steven.
    In: Working Papers.
    RePEc:chy:respap:54cherp.

    Full description at Econpapers || Download paper

31. Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?. (2009). Johannesson, Magnus ; Zethraeus, N ; Jonsson, L ; Kobelt, G.
    In: Briefing.
    RePEc:ohe:briefg:000228.

    Full description at Econpapers || Download paper

Report date: 2025-10-05 04:37:59 || Missing content? Let us know